NO942707L - Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner - Google Patents
Syntetiske peptider egnet for vaksine mot rubellsinfeksjonerInfo
- Publication number
- NO942707L NO942707L NO942707A NO942707A NO942707L NO 942707 L NO942707 L NO 942707L NO 942707 A NO942707 A NO 942707A NO 942707 A NO942707 A NO 942707A NO 942707 L NO942707 L NO 942707L
- Authority
- NO
- Norway
- Prior art keywords
- rubella
- synthetic peptides
- peptides suitable
- vaccine
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36211—Rubivirus, e.g. rubella virus
- C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929201139A GB9201139D0 (en) | 1992-01-20 | 1992-01-20 | Synthetic peptides for a rubella vaccine |
| PCT/CA1993/000014 WO1993014206A2 (fr) | 1992-01-20 | 1993-01-20 | Peptides synthetiques destines a un vaccin contre la rubeole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO942707D0 NO942707D0 (no) | 1994-07-19 |
| NO942707L true NO942707L (no) | 1994-09-20 |
Family
ID=10708876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942707A NO942707L (no) | 1992-01-20 | 1994-07-19 | Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6037448A (fr) |
| EP (1) | EP0624198A1 (fr) |
| JP (1) | JPH07503133A (fr) |
| AU (1) | AU662954B2 (fr) |
| CA (1) | CA2128407C (fr) |
| FI (1) | FI943418L (fr) |
| GB (1) | GB9201139D0 (fr) |
| NO (1) | NO942707L (fr) |
| RU (1) | RU94040393A (fr) |
| WO (1) | WO1993014206A2 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5427792A (en) * | 1989-08-23 | 1995-06-27 | Biochem Immunosystems, Inc. | Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus |
| WO1997026538A1 (fr) * | 1996-01-19 | 1997-07-24 | Virginia Mason Research Center | Strategie de determinant antigenique de peptide specifique d'un allele aux fins de la mise au point de vaccin |
| CA2238660A1 (fr) * | 1998-05-22 | 1999-11-22 | Janet Chantler | Sequences des genes du virus de la rubeole associees a l'attenuation |
| SE9903031D0 (sv) * | 1999-08-27 | 1999-08-27 | Eurodiagnostica Ab | Peptide mixture and vaccine against a chronic viral infection |
| DE60229867D1 (de) * | 2001-07-02 | 2008-12-24 | Merrion Res Iii Ltd | Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen |
| WO2009016639A2 (fr) | 2007-08-02 | 2009-02-05 | Biondvax Pharmaceuticals Ltd. | Vaccins contre la grippe à multiples épitopes multimères |
| WO2012114323A1 (fr) | 2011-02-22 | 2012-08-30 | Biondvax Pharmaceuticals Ltd. | Polypeptides multimères multi-épitopes utilisés dans des vaccins contre la grippe saisonnière et pandémique |
| CN107098980A (zh) * | 2017-06-28 | 2017-08-29 | 潍坊汉唐生物工程有限公司 | 一种检测风疹病毒抗体的融合蛋白及其制备方法 |
| CN116376977B (zh) * | 2023-03-23 | 2024-11-19 | 北京巴瑞医疗器械有限公司 | 风疹病毒重组病毒样颗粒表达载体及其用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0299673A1 (fr) * | 1987-07-08 | 1989-01-18 | London Biotechnology Limited | Antigène de la glycoprotéine E1 de la rubéole |
| US5164481A (en) * | 1989-08-23 | 1992-11-17 | Iaf Biochem International Inc. | Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus |
-
1992
- 1992-01-20 GB GB929201139A patent/GB9201139D0/en active Pending
-
1993
- 1993-01-20 CA CA002128407A patent/CA2128407C/fr not_active Expired - Lifetime
- 1993-01-20 FI FI943418A patent/FI943418L/fi not_active Application Discontinuation
- 1993-01-20 WO PCT/CA1993/000014 patent/WO1993014206A2/fr not_active Ceased
- 1993-01-20 US US08/256,747 patent/US6037448A/en not_active Expired - Lifetime
- 1993-01-20 JP JP5512042A patent/JPH07503133A/ja active Pending
- 1993-01-20 EP EP93901999A patent/EP0624198A1/fr not_active Withdrawn
- 1993-01-20 RU RU94040393/13A patent/RU94040393A/ru unknown
- 1993-01-20 AU AU33413/93A patent/AU662954B2/en not_active Ceased
-
1994
- 1994-07-19 NO NO942707A patent/NO942707L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO942707D0 (no) | 1994-07-19 |
| GB9201139D0 (en) | 1992-03-11 |
| EP0624198A1 (fr) | 1994-11-17 |
| FI943418A0 (fi) | 1994-07-19 |
| CA2128407A1 (fr) | 1993-07-22 |
| AU662954B2 (en) | 1995-09-21 |
| WO1993014206A2 (fr) | 1993-07-22 |
| FI943418A7 (fi) | 1994-09-15 |
| US6037448A (en) | 2000-03-14 |
| WO1993014206A3 (fr) | 1993-10-28 |
| AU3341393A (en) | 1993-08-03 |
| FI943418L (fi) | 1994-09-15 |
| CA2128407C (fr) | 2002-04-09 |
| JPH07503133A (ja) | 1995-04-06 |
| RU94040393A (ru) | 1996-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU591054B2 (en) | Pre-S gene coded peptide hepatitis B immunogens, vaccines and diagnostics | |
| RU94040386A (ru) | Синтетический пептид, синтетический липопептид, иммуногенный коньюгат, вектор, диагностический реагент, метод определения инфекций, антитета, способ получения олигомера, синтетическая вакцина против haemophilus influenzae, защищенный полисахарид | |
| NO913518L (no) | Vaksiner for ikke typebestembar haemophilus influenzae. | |
| ATE244891T1 (de) | Verfahren zur selektion und produktion von t-zell-peptide epitope und vakzine mit diese epitope | |
| EP0243913A3 (fr) | Immunogènes peptidiques de l'hépatite B codés par le gène pre-S, vaccins, produits de diagnostic et vésicules de transport lipidique synthétiques | |
| ATE298798T1 (de) | Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin | |
| DK0661999T3 (da) | Vacciner mod felint immundefekt virus (FIV) | |
| NO319525B1 (no) | Fremgangsmate for a danne et konjugat av et helt hemagglutinin,HA, protein av influensavirus samt fremgangsmate for fremstilling av et immunologisk preparat omfattende konjugatet. | |
| ATE134195T1 (de) | Peptidfragmente von hiv | |
| ATE162550T1 (de) | Ospc-antigen-impfstoffe immunogene zusammensetzung zur vorbeugung und behandlung von lyme-krankheit und rekombinante verfahren zur herstellung von derartige antigene | |
| RU94040393A (ru) | Синтетические пептиды для вакцины против краснухи | |
| ATE221786T1 (de) | Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus | |
| ATA171686A (de) | Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen | |
| CA2521038A1 (fr) | Polypeptide comprenant un motif d'adhesion cellulaire, un epitope de lymphocyte t et un epitope de lymphocyte b utilise pour induire la production d'anticorps | |
| AU4712993A (en) | New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods | |
| GR1000321B (el) | Ανασυνδυασμενες διαλυτες πρωτεινες για την μεταβολη της ορμονικ σ εκκρισεως. | |
| BRPI0009746B8 (pt) | molécula de veículo contendo plasmídeo pg-pviii compreendendo uma seqúência que codifica uma parte de uma glicoproteína de lissavírus contendo pelo menos o sítio iii da glicoproteína de lissavírus mas não contendo o sítio ii, e, composição imunogênica | |
| Rajnavölgyi | Synthetic peptides in the search for T-and B-cell epitopes | |
| Balasa et al. | Immunotargeting of thyroglobulin on antigen presenting cells abrogates natural tolerance in the absence of adjuvant | |
| KR950701821A (ko) | 피임 백신(contraceptive vaccine) | |
| BR9711809A (pt) | Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo | |
| SE9202318D0 (sv) | Nya peptider, diagnostiska antigen, anvaendning daerav, vacciner och medikamenter | |
| CA2347278A1 (fr) | Vaccin a base d'haemophilus somnus attenue | |
| ES1027961U (es) | Soporte publicitario para carritos. | |
| ES2065254A1 (es) | Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados. |